Chemed (NYSE:CHE) Hits New 52-Week High - Time to Buy?

Key Points

• Chemed reached a new 52-week high of $551.74, while shares last traded near $544.67. The stock has a market capitalization of approximately $7.11 billion and trades at a P/E ratio of 27.26.
• Recent quarterly results exceeded expectations, with earnings per share of $6.06 versus the $5.60 consensus and revenue of $673.25 million, up 8.8% year over year. The company issued fiscal 2026 EPS guidance of $25.00–$25.75.
• Analyst sentiment remains cautious: Chemed has an average rating of “Hold” and an average price target of $530.75, below its recent trading level. The company pays a quarterly dividend of $0.60, yielding approximately 0.4%, while insiders have sold shares in the past 90 days.

Chemed Corporation (NYSE:CHE - Get Free Report) reached a new 52-week high during trading on Thursday . The stock traded as high as $551.74 and last traded at $544.6710, with a volume of 9304 shares traded. The stock had previously closed at $546.51.

Analysts Set New Price Targets

Several brokerages have commented on CHE. Oppenheimer raised their price target on shares of Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a research note on Friday, July 31st. Bank of America reissued a "neutral" rating on shares of Chemed in a report on Wednesday, July 29th. Zacks Research upgraded Chemed from a "strong sell" rating to a "hold" rating in a research report on Monday, April 27th. Weiss Ratings raised Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. Finally, Royal Bank Of Canada boosted their price target on Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a research report on Thursday, July 30th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $530.75.

Chemed Stock Performance

The stock has a market cap of $7.11 billion, a price-to-earnings ratio of 27.26, a PEG ratio of 2.04 and a beta of 0.51. The company's 50 day simple moving average is $473.28 and its 200 day simple moving average is $438.37. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping analysts' consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same period in the prior year, the business posted $4.27 EPS. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, equities research analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Thursday, May 28th. Chemed's dividend payout ratio is 12.05%.

Insider Buying and Selling at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the business's stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares of the company's stock, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Patrick P. Grace sold 190 shares of the company's stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the sale, the director owned 3,533 shares of the company's stock, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 3,537 shares of company stock valued at $1,782,654. 3.33% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Monetary Solutions Ltd acquired a new stake in Chemed in the 4th quarter valued at about $25,000. Los Angeles Capital Management LLC acquired a new position in shares of Chemed in the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. bought a new stake in shares of Chemed in the 4th quarter worth approximately $27,000. Versant Capital Management Inc raised its holdings in shares of Chemed by 7,500.0% in the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company's stock worth $35,000 after purchasing an additional 75 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB raised its holdings in shares of Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company's stock worth $38,000 after purchasing an additional 32 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source